Having trouble accessing articles? Reset your cache.

NGR-hTNF: Additional Phase II data

Additional data from the open-label, Italian Phase II Study NGR008 trial showed that median PFS in 27 patients who received

Read the full 203 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE